Shigella sonnei vaccines
Latest Information Update: 14 Oct 2009
At a glance
- Originator Israel Defense Force; National Institutes of Health (USA); Walter Reed Army Institute of Research
- Class Bacterial vaccines; Drug conjugates
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Shigella infections